On June 2024, the Supreme Court of India agreed to hear a petition challenging the mandatory use of the apnoea test for brain death certification under the Transplantation of Human Organs and Tissues Act, 1994 (THOTA) and its 2014 Rules. The petition raises concerns about the medical ethics, procedural clarity, and patient rights involved in declaring brain death, a crucial step for organ transplantation. This judicial scrutiny comes amid ongoing debates over the adequacy of brain death diagnosis protocols and the growing demand for organs in India.

Legal Framework Governing Brain Death and Organ Transplantation

The Transplantation of Human Organs and Tissues Act, 1994 defines brain death under Section 2(aa) as the irreversible cessation of all brain functions, including the brainstem. Section 3 mandates certification of brain death by a panel of medical experts. The 2014 Rules under THOTA specify the procedural requirements, including the apnoea test as a compulsory confirmatory step. The test assesses the absence of spontaneous respiration despite elevated carbon dioxide levels, signaling brainstem failure.

• Article 21 of the Constitution guarantees the right to life and personal liberty, encompassing the right to die with dignity and protection against medical negligence.
• The Supreme Court’s landmark judgment in Common Cause vs Union of India (2018) upheld brain death as legal death and emphasized strict adherence to protocols to prevent misuse.
• The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, guide physicians on ethical practices, including informed consent and transparency in brain death certification.

Medical and Ethical Dimensions of the Apnoea Test

The apnoea test is central to brain death certification in India, with over 90% of cases relying on it (ICMR Guidelines 2022). It involves disconnecting the patient from the ventilator to observe if spontaneous breathing resumes, which poses risks such as hypoxia and cardiac instability. Critics argue that the test’s invasive nature and potential complications warrant supplementary ancillary tests to confirm brain death.

• Brain death accounts for approximately 10% of deaths in tertiary care hospitals in India (ICMR 2022), making accurate diagnosis essential for organ donation.
• Ethical concerns include the possibility of premature declaration, inadequate physician training, and lack of patient/family counseling.
• The absence of uniform ancillary testing protocols increases medico-legal risks and public distrust.

Economic and Institutional Context

India’s organ transplantation market is valued at USD 1.2 billion in 2023 and is growing at a CAGR of 12.5% (FICCI Health Report 2023). Despite this, organ donation rates remain critically low at 0.08 per million population compared to the global average of 20 per million (NOTTO 2023). The shortage results in an estimated annual economic loss of INR 2000 crore due to prolonged treatments and dialysis (NITI Aayog Health Report 2022).

• National Organ and Tissue Transplant Organisation (NOTTO) coordinates organ donation and transplantation at the national level.
• State Organ and Tissue Transplant Organisations (SOTTOs) implement and monitor protocols regionally.
• Indian Council of Medical Research (ICMR) issues clinical guidelines and supports research on brain death and transplantation.
• Ministry of Health and Family Welfare (MoHFW) formulates policies and allocates INR 50 crore annually for awareness and infrastructure under NOTTO.

Comparative Analysis: India and the United Kingdom

Critical Gaps and Challenges in India

• Lack of standardized ancillary testing protocols to supplement the apnoea test increases risk of misdiagnosis.
• Insufficient training and certification of physicians conducting brain death tests.
• Low public awareness about brain death and organ donation contributes to family refusals.
• Medico-legal ambiguities fuel hesitance among medical practitioners and institutions.
• Inadequate infrastructure and budgetary support at state levels limit effective implementation.

Significance and Way Forward

• The Supreme Court’s examination offers an opportunity to clarify legal and procedural ambiguities surrounding brain death certification.
• Mandating ancillary tests alongside the apnoea test can enhance diagnostic accuracy and reduce ethical dilemmas.
• Strengthening physician training and certification protocols is essential to uphold medical ethics and patient rights.
• Expanding public awareness campaigns and counseling mechanisms can improve organ donation consent rates.
• Policy reforms should focus on harmonizing national and state-level efforts, backed by increased budget allocation.

Jharkhand & JPSC Relevance

• JPSC Paper: Paper 2 (Health and Social Issues), Paper 4 (Ethics and Governance)
• Jharkhand Angle: Jharkhand has low organ donation awareness and infrastructure, mirroring national challenges; brain death certification protocols impact tertiary hospitals in Ranchi and Dhanbad.
• Mains Pointer: Frame answers highlighting legal provisions under THOTA, challenges in rural and tribal healthcare settings, and the need for state-level capacity building in brain death diagnosis and organ donation awareness.